Tu2023 EXPLORING THE ROLE OF VOLIXIBAT, AN ILEAL BILE ACID TRANSPORTER INHIBITOR, IN THE REGULATION OF IL-31 AND SERUM BILE ACIDS IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS: PRELIMINARY RESULTS FROM THE VANTAGE TRIAL
Mitchell L. Shiffman, Alan Bonder, Debra Weinstein, Victor Ankoma-Sey et autres